The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical Research
Open accessAbstract
Copper-64 (T(1/2) = 12.7 hours; beta(+), 0.653 MeV [17.8 %]; beta(-), 0.579 MeV [38.4 %]) has decay characteristics that allow for positron emission tomography (PET) imaging and targeted radiotherapy of cancer. The well-established coordination chemistry of copper allows for its reaction with a wide variety of chelator systems that can potentially be linked to peptides and other biologically relevant small molecules, antibodies, proteins, and nanoparticles. The 12.7-hours half-life of 64Cu provides the flexibility to image both smaller molecules and larger, slower clearing proteins and nanoparticles. In a practical sense, the radionuclide or the 64Cu-radiopharmaceuticals can be easily shipped for PET imaging studies at sites remote to the production facility. Due to the versatility of 64Cu, there has been an abundance of novel research in this area over the past 20 years, primarily in the area of PET imaging, but also for the targeted radiotherapy of cancer. The biologic activity of the hypoxia imaging agent, 60/64Cu-ATSM, has been described in great detail in animal models and in clinical PET studies. An investigational new drug application for 64Cu-ATSM was recently approved by the U.S. Food and Drug Administration (FDA) in the United States, paving the way for a multicenter trial to validate the utility of this agent, with the hopeful result being FDA approval for routine clinical use. This article discusses state-of-the-art cancer imaging with 64Cu radiopharmaceuticals, including 64Cu-ATSM for imaging hypoxia, 64Cu-labeled peptides for tumor-receptor targeting, (64)Cu-labeled monoclonal antibodies for targeting tumor antigens, and 64Cu-labeled nanoparticles for cancer targeting. The emphasis of this article will be on the new scientific discoveries involving (64)Cu radiopharmaceuticals, as well as the translation of these into human studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,859
Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery
Liong, M., Lu, J., Kovochich, M., Xia, T., Ruehm, S. G., Nel, A. E., Tamanoi, F., & Zink, J. I. (2008) · ACS Nano · doi:10.1021/nn800072t · Cited by 1,929
Role of integrins in cell invasion and migration
Hood, J. D., & Cheresh, D. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc727 · Cited by 1,777
Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schäffer, U., & Vaupel, P. W. (1996) · PubMed · Cited by 1,727
Xiong, J.-P., Stehle, T., Zhang, R., Joachimiak, A., Frech, M., Goodman, S. L., & Arnaout, M. A. (2002) · Science · doi:10.1126/science.1069040 · Cited by 1,613
In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice
Liu, Z., Cai, W., He, L., Nakayama, N., Chen, K., Sun, X., Chen, X., & Dai, H. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2006.170 · Cited by 1,436
Copper biochemistry and molecular biology
Linder, M. C., & Hazegh-Azam, M. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.5.797 · Cited by 1,430
Dendrimers and dendritic polymers in drug delivery
Gillies, E. R., & Fréchet, J. M. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03276-3 · Cited by 1,367
SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
Bauer, W., Briner, U., Doepfner, W., Haller, R., Huguenin, R., Marbach, P., Petcher, T. J., & Pless, J. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90087-x · Cited by 1,331
In vivo Biodistribution and Highly Efficient Tumour Targeting of Carbon Nanotubes in Mice
Liu, Z., Cai, W., He, L., Nakayama, N., Chen, K., Sun, X., Chen, X., & Dai, H. (2020) · Nano-Enabled Medical Applications · doi:10.1201/9780429399039-14 · Cited by 1,213
Nanoshell-Enabled Photonics-Based Imaging and Therapy of Cancer
Loo, C., Lin, A., Hirsch, L., Lee, M.-H., Barton, J., Halas, N., West, J., & Drezek, R. (2004) · Technology in Cancer Research & Treatment · doi:10.1177/153303460400300104 · Cited by 1,160
Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.
Brooks, P. C., Strömblad, S., Klemke, R., Visscher, D., Sarkar, F. H., & Cheresh, D. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118227 · Cited by 828
Albelda, S. M., Mette, S. A., Elder, D. E., Stewart, R., Damjanovich, L., Herlyn, M., & Buck, C. A. (1990) · PubMed · Cited by 760
Brown, J. M. (1999) · PubMed · Cited by 698
Carbon Nanotube Amplification Strategies for Highly Sensitive Immunodetection of Cancer Biomarkers
Yu, X., Munge, B., Patel, V., Jensen, G., Bhirde, A., Gong, J. D., Kim, S. N., Gillespie, J., Gutkind, J. S., Papadimitrakopoulos, F., et al. (2006) · Journal of the American Chemical Society · doi:10.1021/ja062117e · Cited by 686
Linder, M. C. (1991) · Springer eBooks · doi:10.1007/978-1-4757-9432-8 · Cited by 626
Tatum, J. L. (2006) · International Journal of Radiation Biology · doi:10.1080/09553000601002324 · Cited by 620
Noninvasive molecular imaging of small living subjects using Raman spectroscopy
Keren, S., Zavaleta, C., Cheng, Z., de la Zerda, A., Gheysens, O., & Gambhir, S. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710575105 · Cited by 604
Integrins: roles in cancer development and as treatment targets
Jin, H., & Varner, J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601576 · Cited by 574
Lee, H.-Y., Li, Z., Chen, K., Hsu, A. R., Xu, C., Xie, J., Sun, S., & Chen, X. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.051243 · Cited by 557
Efficient production of high specific activity 64Cu using a biomedical cyclotron
McCarthy, D. W., Shefer, R. E., Klinkowstein, R. E., Bass, L. A., Margeneau, W. H., Cutler, C. S., Anderson, C. J., & Welch, M. J. (1997) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(96)00157-6 · Cited by 533
Self-citationGinj, M., Zhang, H., Waser, B., Cescato, R., Wild, D., Wang, X., Erchegyi, J., Rivier, J., Mäcke, H. R., & Reubi, J. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607761103 · Cited by 515
Hirsch, L. R., Gobin, A. M., Lowery, A. R., Tam, F., Drezek, R. A., Halas, N. J., & West, J. L. (2006) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-9001-8 · Cited by 497
Boswell, C. A., Sun, X., Niu, W., Weisman, G. R., Wong, E. H., Rheingold, A. L., & Anderson, C. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030383m · Cited by 483
Self-citationCopper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential.
Fujibayashi, Y., Taniuchi, H., Yonekura, Y., Ohtani, H., Konishi, J., & Yokoyama, A. (1997) · PubMed · Cited by 481
Nanotechnological applications in medicine
Caruthers, S. D., Wickline, S. A., & Lanza, G. M. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.01.006 · Cited by 441
Dual-Function Probe for PET and Near-Infrared Fluorescence Imaging of Tumor Vasculature
Cai, W., Chen, K., Li, Z.-B., Gambhir, S. S., & Chen, X. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.043216 · Cited by 429
Krenning, E. P., Bakker, W., Kooij, P. P. M., Breeman, W. A., Oei, H. Y., de Jong, M., Reubi, J. C., Visser, T. J., Bruns, C., & Kwekkeboom, D. J. (1992) · PubMed · Cited by 420
In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM
Dehdashti, F., Mintun, M. A., Lewis, J. S., Bradley, J., Govindan, R., Laforest, R., Welch, M. J., & Siegel, B. A. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1130-4 · Cited by 368
The αvβ3 integrin “vitronectin receptor”
Horton, M. A. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00155-0 · Cited by 348
Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy.
Mendelsohn, J. M. (1997) · PubMed · Cited by 344
αvβ3 and αvβ5 Integrin Expression in Glioma Periphery
Bello, L., Francolini, M., Marthyn, P., Zhang, J., Carroll, R. S., Nikas, D. C., Strasser, J. F., Villani, R., Cheresh, D. A., & Black, P. M. (2001) · Neurosurgery · doi:10.1097/00006123-200108000-00022 · Cited by 341
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen, M. L., Oyen, W. J. G., Dijkgraaf, I., Massuger, L. F. A. G., Frielink, C., Edwards, D. S., Rajopadhye, M., Boonstra, H., Corstens, F. H. M., & Boerman, O. C. (2002) · PubMed · Cited by 331
Dehdashti, F., Grigsby, P. W., Mintun, M. A., Lewis, J. S., Siegel, B. A., & Welch, M. J. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04477-2 · Cited by 326
Wu, Y., Zhang, X., Xiong, Z., Cheng, Z., Fisher, D. R., Liu, S., Gambhir, S. S., & Chen, X. S. (2005) · PubMed · Cited by 325
Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.
Lewis, J. S., Mccarthy, D. W., McCarthy, T. J., et al. (1999) · PubMed · Cited by 323
In Vivo Transchelation of Copper-64 from TETA-Octreotide to Superoxide Dismutase in Rat Liver
Bass, L. A., Wang, M., Welch, M. J., & Anderson, C. J. (2000) · Bioconjugate Chemistry · doi:10.1021/bc990167l · Cited by 311
Self-citationCopper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships
Dearling, J. L. J., Lewis, J. S., Mullen, G. E. D., Welch, M. J., & Blower, P. J. (2002) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s007750100291 · Cited by 277
64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.
Anderson, C. J., Dehdashti, F., Cutler, P. D., Schwarz, S. W., Laforest, R. A., Bass, L. A., Lewis, J. S., & Mccarthy, D. W. (2001) · PubMed · Cited by 273
Self-citationKobayashi, H., Kawamoto, S., Jo, S.-K., Bryant, H. L., Brechbiel, M. W., & Star, R. A. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025633c · Cited by 262
Chen, X., Park, R., Tohme, M., Shahinian, A. H., Bading, J. R., & Conti, P. S. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0300403 · Cited by 260
Mulder, W. J. M., Strijkers, G. J., Habets, J. W., Bleeker, E. J. W., van der Schaft, D. W. J., Storm, G., Koning, G. A., Griffioen, A. W., & Nicolay, K. (2005) · The FASEB Journal · doi:10.1096/fj.05-4145fje · Cited by 259
Lukeš, I., Kotek, J., Vojtišek, P., & Hermann, P. (2001) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(01)00336-8 · Cited by 256
Chen, X. S., Hou, Y., Tohme, M. S., Park, R. J.-H., Khankaldyyan, V., Gonzales-Gomez, I., Bading, J. R., Laug, W. E., & Conti, P. S. (2004) · PubMed · Cited by 254
Epidermal growth factor receptor: a promising target in solid tumours
Laskin, J. J., & Sandler, A. B. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.10.002 · Cited by 253
Li, Z.-B., Cai, W., Cao, Q., Chen, K., Wu, Z., He, L., & Chen, X. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.039859 · Cited by 251
Fan, Z., Masui, H., Altas, I., & Mendelsohn, J. M. (1993) · PubMed · Cited by 245
Cai, W., Chen, K., He, L., Cao, Q., Koong, A., & Chen, X. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0361-6 · Cited by 241
Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications
Sosnovik, D. E., Nahrendorf, M., & Weissleder, R. (2008) · Basic Research in Cardiology · doi:10.1007/s00395-008-0710-7 · Cited by 229
Involvement of αvβ3 integrins in osteoclast function
Nakamura, I., Duong, L. T., Rodan, S. B., & Rodan, G. A. (2007) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-007-0773-9 · Cited by 224
Sun, X., Rossin, R., Turner, J. L., Becker, M. L., Joralemon, M. J., Welch, M. J., & Wooley, K. L. (2005) · Biomacromolecules · doi:10.1021/bm050260e · Cited by 223
de Jong, M., Bakker, W. H., Krenning, E. P., Breeman, W. A. P., van der Pluijm, M. E., Bernard, B. F., Visser, T. J., Jermann, E., Béhé, M., Powell, P., et al. (1997) · European Journal of Nuclear Medicine · doi:10.1007/bf00881807 · Cited by 215
Copper-64-diacetyl-bis( N 4 -methylthiosemicarbazone): An agent for radiotherapy
Lewis, J. S., Laforest, R., Buettner, T. L., Song, S.-K., Fujibayashi, Y., Connett, J. M., & Welch, M. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1206 · Cited by 213
MicroPET imaging of breast cancer ?-integrin expression with Cu-labeled dimeric RGD peptides
CHEN, X., LIU, S., HOU, Y., TOHME, M., PARK, R., BADING, J., & CONTI, P. (2004) · Molecular Imaging & Biology · doi:10.1016/j.mibio.2004.06.004 · Cited by 212
Dehdashti, F., Grigsby, P. W., Lewis, J. S., Laforest, R., Siegel, B. A., & Welch, M. J. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.048520 · Cited by 212
Imaging of integrin αvβ3 expression
Beer, A. J., & Schwaiger, M. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9158-3 · Cited by 211
de Jong, M., Breeman, W. A., Bakker, W., Kooij, P. P. M., Bernard, B. F., Hofland, L. J., Visser, T. J., Srinivasan, A., Schmidt, M. A., Erion, J. L., et al. (1998) · PubMed · Cited by 209
Wong, E. H., Weisman, G. R., Hill, D. C., Reed, D. P., Rogers, M. E., Condon, J. S., Fagan, M. A., Calabrese, J. C., Lam, K., Guzei, I. A., et al. (2000) · Journal of the American Chemical Society · doi:10.1021/ja001295j · Cited by 207
Moi, M. K., Meares, C. F., McCall, M. J., et al. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90653-0 · Cited by 196
An Imaging Comparison of 64Cu-ATSM and 60Cu-ATSM in Cancer of the Uterine Cervix
Lewis, J. S., Laforest, R., Dehdashti, F., Grigsby, P. W., Welch, M. J., & Siegel, B. A. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.051326 · Cited by 187
Integrin αβ3-Targeted Imaging of Lung Cancer
Chen, X., Sievers, E., Hou, Y., Park, R., Tohme, M., Bart, R., Bremner, R., Bading, J. R., & Conti, P. S. (2005) · Neoplasia · doi:10.1593/neo.04538 · Cited by 176
Cross-bridged cyclam. Protonation and lithium cation (Li+) complexation in a diamond-lattice cleft
Weisman, G. R., Rogers, M. E., Wong, E. H., Jasinski, J. P., & Paight, E. S. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00179a067 · Cited by 165
Sprague, J. E., Peng, Y., Sun, X., Weisman, G. R., Wong, E. H., Achilefu, S., & Anderson, C. J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1084 · Cited by 158
Self-citationKimura, R. H., Cheng, Z., Gambhir, S. S., & Cochran, J. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2495 · Cited by 158
Synthesis and Characterization of Core–Shell Star Copolymers for In Vivo PET Imaging Applications
Fukukawa, K., Rossin, R., Hagooly, A., Pressly, E. D., Hunt, J. N., Messmore, B. W., & Hawker, C. J. (2008) · Biomacromolecules · doi:10.1021/bm7014152 · Cited by 153
Peptides and Metallic Nanoparticles for Biomedical Applications
Kogan, M. J., Olmedo, I., Hosta‐Rigau, L., Guerrero, A. R., Cruz, L. J., & Alberício, F. (2007) · Nanomedicine · doi:10.2217/17435889.2.3.287 · Cited by 153
Saito, R., Krauze, M. T., Bringas, J. R., Noble, C. O., McKnight, T. R., Jackson, P., Wendland, M. F., Mamot, C., Drummond, D. C., Kirpotin, D. B., et al. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.08.016 · Cited by 150
Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy
van Hagen, P. M., Breeman, W. A. P., Bernard, H. F., Schaar, M., Mooij, C. M., Srinivasan, A., Schmidt, M. A., Krenning, E. P., & de Jong, M. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000820)90:4<186::aid-ijc2>3.0.co;2-p · Cited by 142
Pressly, E. D., Rossin, R., Hagooly, A., Fukukawa, K., Messmore, B. W., Welch, M. J., Wooley, K. L., Lamm, M. S., Hule, R. A., Pochan, D. J., et al. (2007) · Biomacromolecules · doi:10.1021/bm700541e · Cited by 140
Li, W. P., Meyer, L. A., Capretto, D. A., Sherman, C. D., & Anderson, C. J. (2008) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2007.0444 · Cited by 135
Self-citationRadiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats.
Anderson, C. J., Jones, L. A., Bass, L. A., Sherman, E., Mccarthy, D. W., Cutler, P. D., Lanahan, M. V., Cristel, M. E., Lewis, J. S., & Schwarz, S. W. (1998) · PubMed · Cited by 133
Self-citationImaging of Melanoma Using 64Cu− and 86Y−DOTA−ReCCMSH(Arg11), a Cyclized Peptide Analogue of α-MSH
Mcquade, P. S., Miao, Y., Yoo, J., Quinn, T. P., Welch, M. J., & Lewis, J. S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0490282 · Cited by 129
Shi, J., Kim, Y., Zhai, S., Liu, Z., Chen, X. S., & Liu, S. (2009) · Bioconjugate Chemistry · doi:10.1021/bc800455p · Cited by 127
Fujibayashi, Y., Cutler, C., Anderson, C. J., Mccarthy, D. W., Jones, L. A., Sharp, T. L., Yonekura, Y., & Welch, M. J. (1999) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(98)00049-3 · Cited by 116
Self-citationDosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET
Laforest, R. A., Dehdashti, F., Lewis, J. S., & Schwarz, S. W. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1756-x · Cited by 97
Wei, L., Ye, Y., Wadas, T. J., Lewis, J. S., Welch, M. J., Achilefu, S. A., & Anderson, C. J. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2008.12.008 · Cited by 95
Self-citationSun, G., Hagooly, A., Xu, J., Nyström, A. M., Li, Z., Rossin, R., Moore, D. A., Wooley, K. L., & Welch, M. J. (2008) · Biomacromolecules · doi:10.1021/bm800246x · Cited by 89
Lewis, J. S., Srinivasan, A., Schmidt, M. A., & Anderson, C. J. (1999) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(98)00105-x · Cited by 89
Self-citationRadiolabeling of TETA- and CB-TE2A-conjugated peptides with copper-64
Wadas, T. J., & Anderson, C. J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.431 · Cited by 88
Self-citationDence, C. S., Ponde, D. E., Welch, M. J., & Lewis, J. S. (2008) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2008.06.001 · Cited by 85
Perspectives on copper biochemistry.
Frieden, E. (1986) · PubMed · Cited by 82
Xue, C., Voss, M. E., Nelson, D. J., Duan, J. J. ‐., Cherney, R. J., Jacobson, I. C., He, X., Roderick, J. J., Chen, L., Corbett, R. L., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010127e · Cited by 79
Ultra rigid cross-bridged tetraazamacrocycles as ligands—the challenge and the solution
Hubin, T. J., McCormick, J. M., Collinson, S. R., Busch, D. H., & Alcock, N. W. (1998) · Chemical Communications · doi:10.1039/a802060d · Cited by 78
Wadas, T. J., Eiblmaier, M., Zheleznyak, A., Sherman, C. D., Ferdani, R., Liang, K., Achilefu, S., & Anderson, C. J. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.054502 · Cited by 73
Self-citationMarsh, J. N., Partlow, K. C., Abendschein, D. R., Scott, M. J., Lanza, G. M., & Wickline, S. A. (2007) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2006.12.007 · Cited by 69
Holland, J. P., Barnard, P. J., Collison, D., Dilworth, J. R., Edge, R., Green, J. C., & McInnes, E. J. L. (2008) · Chemistry - A European Journal · doi:10.1002/chem.200800539 · Cited by 69
Recent Advances in Nanooncology
Jain, K. K. (2008) · Technology in Cancer Research & Treatment · doi:10.1177/153303460800700101 · Cited by 64
Hubin, T. J., McCormick, J. M., Alcock, N. W., Clase, H. J., & Busch, D. H. (1999) · Inorganic Chemistry · doi:10.1021/ic990491s · Cited by 60
Sprague, J., Kitaura, H., Zou, W., Ye, Y., Achilefu, S., Weilbaecher, K. N., Teitelbaum, S. L., & Anderson, C. J. (2007) · PubMed · Cited by 58
Self-citationSynthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles.
Shokeen, M., Fettig, N., & Rossin, R. (2008) · PubMed · Cited by 52
Hubin, T. J., Alcock, N. W., Morton, M., & Busch, D. H. (2003) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(03)00036-7 · Cited by 52
Novel Paramagnetic Contrast Agents for Molecular Imaging and Targeted Drug Delivery
Lanza, G. M., Winter, P. M., Caruthers, S. D., Schmeider, A. H., Crowder, K., Morawski, A. M., Zhang, H., Scott, M. J., & Wickline, S. A. (2004) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201043376544 · Cited by 48
Xu, J., Sun, G., Rossin, R., Hagooly, A., Li, Z., Fukukawa, K., Messmore, B. W., Moore, D. A., Welch, M. J., Hawker, C. J., et al. (2007) · Macromolecules · doi:10.1021/ma070267j · Cited by 45
Lewis, M. R., Boswell, C. A., Laforest, R. A., Buettner, T. L., Ye, D., Connett, J. M., & Anderson, C. J. (2001) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/10849780152752083 · Cited by 45
Self-citationThe hypoxic cell a target for selective cancer therapy
Michalski, B., Banyś, A., Drosdzol, A., Skrzypulec, V., & Mazurek, U. M. (2009) · Menopause Review/Przegląd Menopauzalny · Cited by 45
Cited by
Targeting copper in cancer therapy: ‘Copper That Cancer’
Denoyer, D., Masaldan, S., La Fontaine, S., & Cater, M. A. (2015) · Metallomics · doi:10.1039/c5mt00149h · Cited by 806
García, K. P., Zarschler, K., Barbaro, L., Barreto, J. A., O'Malley, W., Spiccia, L., Stephan, H., & Graham, B. (2014) · Small · doi:10.1002/smll.201303540 · Cited by 519
Poly(2‐Oxazoline)s – Are They More Advantageous for Biomedical Applications Than Other Polymers?
Sedlacek, O., Monnery, B. D., Filippov, S. K., Hoogenboom, R., & Hruby, M. (2012) · Macromolecular Rapid Communications · doi:10.1002/marc.201200453 · Cited by 312
Metadata
- Authors
- Anderson, C. J., & Ferdani, R.
- Venue
- Cancer Biotherapy and Radiopharmaceuticals
- Publisher
- SAGE Publications
- Published
- 2009-08
- Volume
- 24
- Issue
- 4
- Pages
- 379-393
- ISSN
- 1084-9785 (ISSN-L)
- 1557-8852
- OpenAlex
- W2137792756
- Cited by
- 374
- References
- 96
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.